You are here

Biomedicine

Resistència quimioteràpia
10.11.2016

The IDIBELL group led by Manel Esteller has identified a molecular mechanism that mainly affects colorectal and stomach cancers

Equip CRG
24.11.2016

Researchers at the CRG and UPF have developed a new technique improving on current treatment strategies

Bdebate 1502
13.02.2015

B·Debate and the Banc de Sang i Teixits will bring together top experts in advanced cell therapies

CNAG-CRG
14.12.2015

The 80 research centers in the International Cancer Genome Consortium (ICGC) are working together to identify the changes in cancer genome sequencing

Representants del clúster Kobe visiten Biocat
13.11.2015

The Kobe Biomedical Innovation Cluster is made up of more than 300 biomedical and biopharmaceutical companies

Grup d’Expressió Gènica i Càncer del VHIO
24.11.2015

The new liquid biopsy technique, design by the Vall d’Hebron Institute of Oncology, will allow doctors to analyze circulating DNA and learn about brain tumors without having to do a brain biopsy

Carles Domenech, director general Ability Pharma
06.11.2015

The results come on the heels of the drug receiving FDA designation as an orphan drug

b·debate
02.09.2015

The 2016 B·Debate program features a total of 9 activities that will be carried out in collaboration with noteworthy local research centers and bodies 

23.07.2015

The product, developed by Catalan company Manremyc, will be sold through an agreement with the leading probiotics company in India 

31.07.2015

The study, which was carried out with transgenic worms, paves the way for new lines of research, and the group is looking for funding to determine the conditions that raise levels of this protein.